Targeting IL-4 for the Treatment of Atopic Dermatitis

被引：0
|
作者：
Chiricozzi, Andrea [1 ,2 ]
Maurelli, Martina [3 ]
Peris, Ketty [1 ,2 ]
Girolomoni, Giampiero [3 ]
机构：
[1] Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Sci Med & Chirurg, Dermatol, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Dermatol, Rome, Italy
[3] Univ Verona, Dept Med, Sect Dermatol, Verona, Italy
来源：
IMMUNOTARGETS AND THERAPY | 2020年 / 9卷
关键词：
atopic dermatitis; IL-4; inhibitor; dupilumab; pascolizumab; pitrakinra; TH2; CYTOKINES; STAPHYLOCOCCUS-AUREUS; DERMAL FIBROBLASTS; DENDRITIC CELLS; TRANSGENIC MICE; LESIONAL SKIN; UP-REGULATION; IFN-GAMMA; IN-VITRO; T-CELLS;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Atopic dermatitis (AD) is an immune-mediated inflammatory skin disease characterized by a predominant type 2 immune response. Type 2 immunity is driven by multiple cytokines, including interleukin (IL)-4 and IL-13 that are considered central to AD pathogenesis and key therapeutic targets. The dual inhibition of these two cytokines or the selective inhibition of IL-13 proved elevated efficacy in treating AD, whereas the selective inhibition of IL-4 has been poorly investigated as IL-4 inhibiting agents did not show any advance in clinical development programs. This review describes the pathogenic role of IL-4 in AD and briefly resumes the main features of compounds selectively blocking IL-4.
引用
收藏
页码：151 / 156
页数：6
相关论文
共 50 条
  • [41] Targeting Skin Barrier Function in Atopic Dermatitis
    van den Bogaard, Ellen H.
    Elias, Peter M.
    Goleva, Elena
    Berdyshev, Evgeny
    Smits, Jos P. H.
    Danby, Simon G.
    Cork, Michael J.
    Leung, Donald Y. M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (05) : 1335 - 1346
  • [42] DUPILUMAB Anti-IL-4Rα monoclonal antibody Treatment of atopic dermatitis Treatment of asthma
    Cole, P.
    Stringer, M.
    DRUGS OF THE FUTURE, 2015, 40 (01) : 7 - 13
  • [43] The Future of Atopic Dermatitis Treatment
    Patel, Nupur
    Strowd, Lindsay C.
    MANAGEMENT OF ATOPIC DERMATITIS: METHODS AND CHALLENGES, 2017, 1027 : 185 - 210
  • [44] A key role for IL-13 signaling via the type 2 IL-4 receptor in experimental atopic dermatitis
    Bitton, Almog
    Avlas, Shmuel
    Reichman, Hadar
    Itan, Michal
    Karo-Atar, Danielle
    Azouz, Nurit P.
    Rozenberg, Perri
    Diesendruck, Yael
    Nahary, Limor
    Rothenberg, Marc E.
    Benhar, Itai
    Munitz, Ariel
    SCIENCE IMMUNOLOGY, 2020, 5 (44)
  • [45] Angiogenesis: The major abnormality of the keratin-14 IL-4 Transgenic mouse model of atopic dermatitis
    Agha-Majzoub, R
    Becker, RP
    Schraufnagel, DE
    Chan, LS
    MICROCIRCULATION, 2005, 12 (06) : 455 - 476
  • [46] Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis.
    Neis, Mark M.
    Peters, Bettina
    Dreuw, Alexandra
    Wenzel, Joerg
    Bieber, Thomas
    Mauch, Cornelia
    Krieg, Thomas
    Stanzel, Sven
    Heinrich, Peter C.
    Merk, Hans F.
    Bosio, Andreas
    Baron, Jens M.
    Hermanns, Heike M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 118 (04) : 930 - 937
  • [47] Role of vitamin D in the pathogenesis and treatment of atopic dermatitis
    Borzutzky, Arturo
    Camargo, Carlos A., Jr.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2013, 9 (08) : 751 - 760
  • [48] IL-15 Expression Pattern in Atopic Dermatitis
    Karlen, Helene
    Yousefi, Shida
    Simon, Hans-Uwe
    Simon, Dagmar
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2020, 181 (06) : 417 - 421
  • [49] Keratinocytes: An Enigmatic Factor in Atopic Dermatitis
    Das, Pamelika
    Mounika, Pappula
    Yellurkar, Manoj Limbraj
    Prasanna, Vani Sai
    Sarkar, Sulogna
    Velayutham, Ravichandiran
    Arumugam, Somasundaram
    CELLS, 2022, 11 (10)
  • [50] Cytokines and T cells in atopic dermatitis
    Auriemma, Matteo
    Vianale, Giovina
    Amerio, Paolo
    Reale, Marcella
    EUROPEAN CYTOKINE NETWORK, 2013, 24 (01) : 37 - 44
12345